Emotional suppression

Emotional suppression is the blunting of emotional responses, in which feelings that would ordinarily arise — grief, joy, fear, affection — are muted or fail to surface at all.

As a drug effect it is acute and dose-proportional, easing as the substance wears off, which sets it apart from the chronic flattening associated with psychiatric conditions. It ranges from mild emotional distance to near-complete numbness.

It is a commonly reported effect across several drug classes. It is most commonly induced at moderate to high doses under depressants such as alprazolam, clonazepam, and diazepam, and under stimulants such as amphetamine and 2-FA; it also appears under deliriants such as diphenhydramine and datura, and as a sustained low-grade form under antidepressants such as mirtazapine.

Emotional suppression is felt as a gap between circumstance and response: events that would normally stir feeling pass with little emotional resonance, and reaching for grief, warmth, or excitement returns something flat.

It commonly comes with a sense of social distance — conversations feel transactional, faces harder to read — and a dulled bodily response, the chest staying loose where emotion would ordinarily tighten it. Searching for the feeling and finding little tends to confirm the emptiness. At high doses, particularly under depressants, this can settle into a broad affective blankness in which almost nothing lands.

Emotional suppression arises through different pathways depending on the drug class:

• Depressants — enhance GABAergic inhibition and reduce overall CNS arousal, dampening the neural circuits that generate and sustain emotional states.
• Stimulants — at moderate to high doses, can redirect attentional resources and elevate dopaminergic tone in ways that override emotional processing rather than amplify it.
• Deliriants — block muscarinic acetylcholine receptors broadly, disrupting the cortical and limbic signaling that underlies emotional awareness.
• Antidepressants — modulate monoaminergic tone; in some individuals this produces blunting as a side effect rather than a therapeutic outcome.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses consistently deepen the effect across all associated classes. Set and setting play a smaller role than with perceptual effects, though people with prior emotional dysregulation or a history of dissociation tend to find it more conspicuous.

Expecting to feel blunted — common among experienced stimulant and depressant users — can amplify it. Familiarity with a substance tends to reduce the effect's salience over repeated use.